Dr. Ross Camidge, University of Colorado, describes ROS-1 rearrangements and compares them to ALK rearrangements in frequency of occurrence and response to treatment.
Targeted Therapies – ROS1
Targeted Therapies – ROS1
If you have been NEWLY DIAGNOSED START HERE
Video Library
Cancer Journey:
Cancer Type:
Disease Learning:
Articles
No Result Found
Community Forum
No Result Found